American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 62, Issue 3, Pages 147-172
Publisher
American Cancer Society
Online
2012-03-15
DOI
10.3322/caac.21139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- ACOG Practice Bulletin No. 109: Cervical Cytology Screening
- (2014) OBSTETRICS AND GYNECOLOGY
- Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003–2005
- (2013) S. Deblina Datta et al. ANNALS OF INTERNAL MEDICINE
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
- (2011) Mark H. Stoler et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
- (2011) Thomas C. Wright et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
- (2011) Susan Hariri et al. CANCER CAUSES & CONTROL
- A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
- (2011) M. Schiffman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
- (2011) Henry C. Kitchener et al. EUROPEAN JOURNAL OF CANCER
- New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
- (2011) Otis Brawley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
- (2011) H.-C. Chen et al. JNCI-Journal of the National Cancer Institute
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
- (2011) Hormuzd A Katki et al. LANCET ONCOLOGY
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
- (2011) Philip E Castle et al. LANCET ONCOLOGY
- Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
- (2011) Dorien C Rijkaart et al. LANCET ONCOLOGY
- Comparative community outreach to increase cervical cancer screening in the Mississippi Delta
- (2011) Philip E. Castle et al. PREVENTIVE MEDICINE
- The cost-effectiveness of male HPV vaccination in the United States
- (2011) Harrell W. Chesson et al. VACCINE
- Special Commentary
- (2010) Walter Kinney et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests
- (2010) Michael J. Thrall et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone
- (2010) Mona Saraiya ARCHIVES OF INTERNAL MEDICINE
- Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
- (2010) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States
- (2010) Xiaocheng Wu et al. CANCER
- Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003
- (2010) Glenn Copeland et al. CANCER
- Cost-effectiveness of human papillomavirus vaccination and screening in Spain
- (2010) Mireia Diaz et al. EUROPEAN JOURNAL OF CANCER
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Practice Improvement in Cervical Screening and Management
- (2010) Philip E. Castle et al. Journal of Lower Genital Tract Disease
- Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
- (2010) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
- (2010) Guglielmo Ronco et al. LANCET ONCOLOGY
- Liquid Compared With Conventional Cervical Cytology
- (2010) Marc Arbyn et al. OBSTETRICS AND GYNECOLOGY
- The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer
- (2010) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
- (2010) Sveinung Wergeland Sørbye et al. PLoS One
- The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
- (2009) Eduardo L. Franco et al. ARCHIVES OF MEDICAL RESEARCH
- Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology
- (2009) Delphine Maucort-Boulch et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening
- (2009) Nancy Thiry et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors
- (2009) Albertus G. Siebers et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Practice Improvement in Cervical Screening and Management (PICSM)
- (2009) Anna-Barbara Moscicki et al. Journal of Lower Genital Tract Disease
- Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
- (2009) Cosette M. Wheeler et al. JNCI-Journal of the National Cancer Institute
- Cervical Intraepithelial Neoplasia Outcomes After Treatment: Long-term Follow-up From the British Columbia Cohort Study
- (2009) J. Melnikow et al. JNCI-Journal of the National Cancer Institute
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Further analysis of the ARTISTIC trial
- (2009) Peter Sasieni et al. LANCET ONCOLOGY
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
- (2009) Henry C Kitchener et al. LANCET ONCOLOGY
- Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries
- (2009) Marc Brisson et al. Public Health Genomics
- The efficacy of HPV 16/18 vaccines on sexually active 18–23 year old women and the impact of HPV vaccination on organized cervical cancer screening
- (2008) Kristjan Sigurdsson et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Trade-offs in Cervical Cancer Prevention
- (2008) Natasha K. Stout et al. ARCHIVES OF INTERNAL MEDICINE
- Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
- (2008) V M H Coupé et al. BRITISH JOURNAL OF CANCER
- Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain
- (2008) A. Gauthier et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness
- (2008) Veerle M.H. Coupé et al. INTERNATIONAL JOURNAL OF CANCER
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
- (2008) J. D. Goldhaber-Fiebert et al. JNCI-Journal of the National Cancer Institute
- Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
- (2008) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
- (2008) Francesca Carozzi et al. LANCET ONCOLOGY
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- What is “quality of evidence” and why is it important to clinicians?
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now